Results 181 to 190 of about 3,418,065 (230)
Some of the next articles are maybe not open access.
Current Treatment Options in Oncology, 2000
Patients with clinically evident medullary thyroid cancer should have a total extracapsular thyroidectomy with bilateral central neck dissection and an ipsilateral prophylactic or therapeutic modified (functional) radical neck dissection when the primary tumor is greater than 1 cm and when the central neck nodes are positive.
E, Kebebew, O H, Clark
openaire +3 more sources
Patients with clinically evident medullary thyroid cancer should have a total extracapsular thyroidectomy with bilateral central neck dissection and an ipsilateral prophylactic or therapeutic modified (functional) radical neck dissection when the primary tumor is greater than 1 cm and when the central neck nodes are positive.
E, Kebebew, O H, Clark
openaire +3 more sources
Medullary thyroid cancer - An update
Best Practice & Research Clinical Endocrinology & Metabolism, 2023Medullary thyroid cancer (MTC) is a rare neuroendocrine disease, encompassing about 5% of all thyroid cancers. Due to its peculiar features, this rare tumour offers unique possibilities for translational research studies. It arises from neuroendocrine parafollicular cells in an endocrine organ, and appears as a nodule apparently indistinguishable from ...
openaire +3 more sources
Otolaryngologic Clinics of North America, 2003
Medullary thyroid cancer is a rare neoplasm that arises from the parafollicular C cells. It occurs in a sporadic form, or less commonly as a hereditary form, as part of multiple endocrine neoplasia syndromes types 2A and 2B. The RET proto-oncogene is currently the primary factor that is implicated in the hereditary forms of this neoplasm. The knowledge
Gary L, Clayman, Tarek S, el-Baradie
openaire +2 more sources
Medullary thyroid cancer is a rare neoplasm that arises from the parafollicular C cells. It occurs in a sporadic form, or less commonly as a hereditary form, as part of multiple endocrine neoplasia syndromes types 2A and 2B. The RET proto-oncogene is currently the primary factor that is implicated in the hereditary forms of this neoplasm. The knowledge
Gary L, Clayman, Tarek S, el-Baradie
openaire +2 more sources
Update on Medullary Thyroid Cancer
Endocrinology and Metabolism Clinics of North America, 2014Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer, demonstrating variable behavior from indolent disease to highly aggressive, progressive disease. There are distinguishing phenotypic features of sporadic and hereditary MTC. Activation or overexpression of cell surface receptors and up-regulation of intracellular signaling pathways in ...
Mimi I, Hu +2 more
openaire +2 more sources
Management of Medullary Thyroid Cancer
Endocrinology and Metabolism Clinics of North America, 2019Medullary thyroid cancer (MTC) is rare but aggressive. It can be cured only if intrathyroid at diagnosis. MTC can be sporadic (75%) or familial (25%) and the 2 forms are distinguished by RET mutations analysis. Calcitonin is the specific serum marker; its doubling time is the most important prognostic factor for survival and progression; 30% of MTC ...
Viola, David, Elisei, Rossella
openaire +3 more sources